Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BML ( (JP:4694) ) just unveiled an update.
BML, Inc. has submitted correction reports for past annual, semi-annual and quarterly securities filings, along with related earnings reports, after discovering errors in the accounting treatment of retirement benefit assets and liabilities. The company determined, in consultation with its audit firm, that it had improperly offset funded retirement benefit assets against obligations and will now apply the correct method retroactively, though it reported no impact on income statements for the affected periods.
The restatements cover the past five fiscal years of annual securities reports and earnings releases, as well as three years of interim and quarterly filings, indicating a broad technical adjustment rather than a change in business performance. While the corrections are not expected to alter reported profits, they may prompt closer investor scrutiny of BML’s internal controls and financial reporting processes, as the company seeks to reassure stakeholders by proactively revising its disclosures.
The most recent analyst rating on (JP:4694) stock is a Hold with a Yen4260.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.
More about BML
BML, Inc. is a Tokyo Prime-listed company operating in Japan’s healthcare and diagnostics sector. The group provides medical testing and related laboratory services, supporting hospitals, clinics, and other healthcare providers with diagnostic data used in treatment and health management.
YTD Price Performance: 3.63%
Average Trading Volume: 59,994
Technical Sentiment Signal: Buy
Current Market Cap: Yen149.6B
Learn more about 4694 stock on TipRanks’ Stock Analysis page.